--Tiny Sub-Cellular Extracellular Vesicles Called Exosomes “Seem to Be Involved in Nearly All Biological & Clinical Processes"
--Huge Medical Potential Is Described
--Author Says Breast Milk Exosomes Are Strongly Resistant to Noxious Environment of Neonatal Stomach & Survive There for Subsequent Intestinal Absorption to Enable Genetic-Based Altering of Developing Functions in Neonates
--Data Demonstrating Successful Allergy Treatment Using Antigen-Specific, Antibody-Enabled Targeting of Acceptor Cells, Coupled with Delivery of Selected Genetic-Function-Altering MicroRNA, Is Presented
The review article describes exosomes (tiny, lipid-membrane-bounded sacs of molecular cargo) as “a sensational biologic discovery” and suggests their huge potential for enabling a wide range of major new applications, including the treatment of many different diseases, and was published online today (April 27, 2020) in Research Open—Microbiology, Immunology, and Pathology (Volume 2, Issue 1) (https://researchopenworld.com/exosome-extracellular-vesicles-a-vehicle-for-simultaneous-immune-and-genetic-therapy/). Microbiology, Immunology and Pathology (MIP) is an open access, peer-reviewed journal with broad scope, covering all zones of Microbiology, Immunology, and Pathology.
The new open-access short review article is titled “Exosome Extracellular Vesicles: A Vehicle for Simultaneous Immune and Genetic Therapy,” and was authored by Philip Askenase (photo), MD, Professor of Medicine (Clinical Immunology) at the Yale University School of Medicine in the Section of Rheumatology and Clinical Immunology, and former Chief of Allergy & Clinical Immunology at the Yale University School of Medicine.
Login Or Register To Read Full Story